Research programme: synthetic lethal targets modulators therapeutics - Satya Pharma
Alternative Names: Synthetic lethal target modulators - Satya PharmaLatest Information Update: 03 Aug 2022
At a glance
- Originator Satya Pharma
- Class Antineoplastics; Small molecules
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Research Cancer
Most Recent Events
- 19 Jul 2022 Early research in Cancer in India (unspecified route) before July 2022 (Satya Pharma pipeline, July 2022 )